Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
INM

InMed Pharmaceuticals (INM) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $1.36 +2.3% on the day -42.1% over 12 months 52-week range $0.61 – $2.35

Share price and insider trades

INM closeInsider buyInsider sale
0123NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $33 on 2026-07-16 · Vivo Opportunity Cayman Fund, L.P.Bought $924 on 2026-06-30 · Vivo Opportunity, LlcBought $2,491 on 2026-07-02 · Vivo Opportunity, LlcBought $2,997 on 2026-10-08 · Adar1 Capital Management, LlcBought $4,051 on 2026-10-07 · Adar1 Capital Management, LlcBought $6,733 on 2026-07-01 · Vivo Opportunity, LlcBought $7,436 on 2026-10-06 · Adar1 Capital Management, LlcBought $8,331 on 2026-07-14 · Vivo Opportunity Cayman Fund, L.P.Bought $10,587 on 2026-06-04 · Vivo Opportunity, LlcBought $10,759 on 2026-09-16 · Daniel SchneebergerBought $11,048 on 2026-10-02 · Adar1 Capital Management, LlcBought $12,064 on 2026-06-03 · Vivo Opportunity, LlcBought $21,850 on 2026-10-01 · Adar1 Capital Management, LlcBought $24,182 on 2026-10-05 · Adar1 Capital Management, LlcBought $25,042 on 2026-07-15 · Adar1 Capital Management, Llc, Vivo Opportunity Cayman Fund, L.P.Bought $25,321 on 2026-06-01 · Vivo Opportunity, LlcBought $27,940 on 2026-05-29 · Vivo Opportunity, LlcBought $34,729 on 2026-06-02 · Vivo Opportunity, LlcBought $36,771 on 2026-09-14 · Daniel SchneebergerBought $49,400 on 2026-06-08 · Vivo Opportunity, LlcBought $57,460 on 2026-05-21 · Vivo Opportunity, LlcBought $70,533 on 2026-09-15 · Daniel SchneebergerBought $86,367 on 2026-06-05 · Vivo Opportunity, LlcBought $87,688 on 2026-05-20 · Vivo Opportunity, LlcBought $721,682 on 2026-05-19 · Daniel Schneeberger
Bought, 12 months$1.3M
Sold, 12 months$0
Insiders buying4
Insiders selling0

InMed Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $1.3M and 0 sold $0 of INM stock on the open market.

INM insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $1.1M bought (23 trades)$1.1MQ2 2026Q3 2026: $161K bought (14 trades)$161KQ3 2026Q4 2026: $72K bought (6 trades)$72KQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$72K6—0
Q3 2026$161K14—0
Q2 2026$1.1M23—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$7.5MDrug Manufacturers - Specialty & Generic
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.3×Last 5 sessions
Insiders' paper profit−$135KOn all tracked purchases -10.0%

Summary

Over the past 12 months, 4 InMed Pharmaceuticals Inc. insiders reported open-market purchases totaling $1.3M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Adar1 Capital Management, Llc (10% Owner) has the highest Insider Score at 67.

INM stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 8SEC Adar1 Capital Management, Llc10% Owner Buy 5,601940,622 held (+1%) $1.33 $7K +2.4% 67
Oct 8SEC Adar1 Capital Management, Llc10% Owner Buy 3,046943,668 held (+0%) $1.33 $4K +2.3% 67
Oct 8SEC Adar1 Capital Management, Llc10% Owner Buy 2,256945,924 held (+0%) $1.33 $3K +2.4% 67
Oct 5SEC Adar1 Capital Management, Llc10% Owner Buy 18,182935,021 held (+2%) $1.33 $24K +2.3% 67
Oct 5SEC Adar1 Capital Management, Llc10% Owner Buy 16,431908,532 held (+2%) $1.33 $22K +2.3% 67
Oct 5SEC Adar1 Capital Management, Llc10% Owner Buy 8,307916,839 held (+1%) $1.33 $11K +2.3% 67
Sep 16SEC Daniel Schneeberger10% Owner Buy 54,256883,761 held (+7%) $1.30 $71K +4.6% 54
Sep 16SEC Daniel Schneeberger10% Owner Buy 28,505829,505 held (+4%) $1.29 $37K +5.4% 54
Sep 16SEC Daniel Schneeberger10% Owner Buy 8,340892,101 held (+1%) $1.29 $11K +5.4% 54
Jul 17SEC Adar1 Capital Management, Llc10% Owner Buy 1,000801,000 held (+0%) $1.56 $2K -12.8% 67
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 13,761743,038 held (+2%) $1.55 $21K -12.3% —
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 4,882729,277 held (+1%) $1.55 $8K -12.3% —
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 1,38975,017 held (+2%) $1.55 $2K -12.3% —
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 49373,628 held (+1%) $1.55 $764 -12.3% —
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 19743,057 held (+0%) $1.55 $29 -12.3% —
Jul 16SEC Vivo Opportunity Cayman Fund, L.P.10% Owner Buy 275,019 held (+0%) $1.55 $3 -12.3% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 3,946722,935 held (+1%) $1.55 $6K -12.3% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 1,460724,395 held (+0%) $1.55 $2K -12.3% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 545718,989 held (+0%) $1.54 $839 -11.7% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 39872,988 held (+1%) $1.55 $617 -12.3% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 14773,135 held (+0%) $1.55 $228 -12.3% —
Jul 2SEC Vivo Opportunity, Llc10% Owner Buy 5572,590 held (+0%) $1.54 $85 -11.7% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 51,056543,129 held (+10%) $1.56 $80K -12.8% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 49,966688,926 held (+8%) $1.57 $78K -13.4% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 30,882574,011 held (+6%) $1.69 $52K -19.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 29,518718,444 held (+4%) $1.52 $45K -10.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 20,753625,766 held (+3%) $1.52 $32K -10.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 16,164590,175 held (+3%) $1.57 $25K -13.4% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 14,838605,013 held (+3%) $1.55 $23K -12.3% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 7,069632,835 held (+1%) $1.55 $11K -12.3% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 6,125638,960 held (+1%) $1.57 $10K -13.4% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 5,15454,833 held (+10%) $1.56 $8K -12.8% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 5,04569,553 held (+8%) $1.57 $8K -13.4% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 3,11857,951 held (+6%) $1.69 $5K -19.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 2,98272,535 held (+4%) $1.52 $5K -10.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 2,09563,176 held (+3%) $1.52 $3K -10.5% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 1,63259,583 held (+3%) $1.57 $3K -13.4% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 1,49861,081 held (+3%) $1.55 $2K -12.3% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 71463,890 held (+1%) $1.55 $1K -12.3% —
Jun 10SEC Vivo Opportunity, Llc10% Owner Buy 61864,508 held (+1%) $1.57 $970 -13.4% —
May 21SEC Daniel Schneeberger10% Owner Buy 200,000600,000 held (+50%) $1.56 $312K -12.8% 54
May 21SEC Daniel Schneeberger10% Owner Buy 200,000800,000 held (+33%) $1.50 $300K -9.3% 54
May 21SEC Daniel Schneeberger10% Owner Buy 68,551400,000 held (+21%) $1.60 $110K -15.0% 54

Insiders at InMed Pharmaceuticals Inc.

InsiderBoughtSoldLast filingScore
Daniel Schneeberger10% Owner $840K — Sep 16, 2026 54
Vivo Opportunity, Llc10% Owner $402K — Jul 2, 2026 —
Adar1 Capital Management, Llc10% Owner $73K — Oct 8, 2026 67
Vivo Opportunity Cayman Fund, L.P.10% Owner $32K — Jul 16, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

INM stock: common questions

Are InMed Pharmaceuticals Inc. insiders buying INM stock?

In the past 12 months, 4 insiders reported open-market purchases of INM worth $1.3M. The latest was 10% Owner Adar1 Capital Management, Llc bought $7K of INM at $1.33.

Are InMed Pharmaceuticals Inc. insiders selling INM stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is INM's 52-week range?

Over the past year INM has traded between $0.61 and $2.35. It last closed at $1.36 on Oct 9, 2026.